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First, let me explain what GRAS means. 
GRAS is an acronym for "generally recognized 
as safe. " It refers to a large number of chemical 
compounds that the FDA considers to be safe 
when added to foods. The legal basis for GRAS 
status is rather complicated and goes back over 
many years to early federal regulations dealing 
with food additives. In 1958 the FDA solicited 
opinions from the scientific community about 
the usefulness and safety of all the substances 
then added to foods, and in 1959 and 1960 had 
lists published in the Federal Register of those 
that were considered GRAS and had not re-
ceived adverse comments.! No further testing 
of the safety of these initial GRAS compounds 
was required, but any new additions to the list 
were expected to be adequately evaluated for 
usefulness and safety. Over the years, GRAS 
status was granted to other compounds by the 
FDA officials by letters of approval, and the 
present number of GRAS substances is proba-
bly in excess of 700 compounds. There are also 
approximately 1,200 natural and synthetic flav-
oring agents added to foods which are generally 
recognized as safe by scientific experts but 
listed separately in the Code of Federal Regu-
lations. 2 
It may surprise pharmacologists familiar with 
the procedure for testing and approval of new 
drugs to learn that the presumed safety of so 
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many chemicals added to foods has been based 
upon common experience in usage and the lack 
of adverse information, rather than extensive 
toxicologic testing and knowledge of their 
biologic effects. 
In 1969, the President directed the FDA to 
re-evaluate the safety status of all the GRAS 
substances. By 1972 a Select Committee was 
established to carry out this assignment under a 
contract from the FDA to the Federation of 
American Societies for Experimental Biology 
(FASEB). The Life Sciences Research Office of 
F ASEB, directed by Dr. C. J. Carr, was the 
organizational base for this task, with a commit-
tee of about twelve members representative of 
the FASEB societies and other relevant scien-
tific disciplines. As one of the members of the 
Select Committee on GRAS substances for 
nearly five years, I have had access to an un-
usual quantity of scientific literature related to 
GRAS substances, including that related to 
possible interactions with therapeutic agents. 
Committee members were provided with 
monographs on each substance summarizing 
the world's scientific literature from 1920 to 
1970, with supplemental material obtained 
through other sources such as Toxline and Med-
line from the National Library of Medicine. 
These resources include considerably more in-
formation on the GRAS substances than interac-
tions with drugs, but the question of possible 
interactions of this type was specifically sought 
out in each literature survey. 
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Table I. GRAS compounds-codes indicating 
purposes of use (Section 12l.IOI, Code of 
Federal Regulations) 
(a) GRAS substances because of common or general 
usage. Examples: salt, sugar, baking powder, 
pepper, monosodium glutamate 
(d) GRAS substances for their intended use: 
(1) Anticaking agents. Examples: tricalcium sili-
cate, magnesium silicate 
(2) Chemical preservatives. Examples: ascorbic 
acid, benzoic acid, butylated hy-
droxyanisole, butylated hydroxy toluene 
(3) Emulsifying agents. Examples: cholic acid, 
glycocholic acid, mono- and diglycer-
ides 
(4) Nutrients and/or dietary supplements. Exam-
ples: amino acids, vitamins, minerals, 
sorbitol 
(5) Sequestrants. Examples: calcium salts, citric 
acid, tartaric acid 
(6) Stabilizers. Examples: plant gums, alginates, 
carrageenan 
(7) Miscellaneous and/or general purpose food 
additives. Examples: acetic acid, bees-
wax, caffeine, gases, lecithin, lactic 
acid, adipic acid 
(e) Spices, seasonings, natural extractives 
(f) Trace minerals added to animal feeds 
(g) Synthetic flavoring substances 
(h) Substances migrating to food from paper and 
paperboard products used in food packaging. 
Examples: clay (kaolin), formic acid, alum, 
casein, ethyl acrylate, silicon dioxides, starch 
(i) Substances migrating to food from cotton and cot-
ton fabrics used in dry food packaging. Exam-
ples: lard, beef tallow, Japan wax, stearic acid 
The Select Committee has been conducting a 
comprehensive review of the safety of each of 
the GRAS substances, writing reports on the 
current health aspects of these compounds with 
opinions and conclusions to the FDA concern-
ing their continued use and status as GRAS 
compounds for the future. Obviously, my 
comments about the work of the Select Com-
mittee and the compounds we are reviewing are 
personal. They do not represent opinions or 
conclusions of the Committee, or those of the 
FDA. 
Before discussing possible interactions be-
tween GRAS substances and drugs it is impor-
tant to describe in more specific terms what 
types of compounds are included within the 
roughly 700 GRAS substances. There is no 
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official, complete published list that can be ref-
erenced. The Select Committee has compiled a 
reasonably comprehensive list with the help of 
the FDA, and this will be included in a publica-
tion from the Select Committee in the near fu-
ture. For this paper, it may be sufficient to indi-
cate some of the general classes of compounds, 
according to use, with a few representative 
examples (Table I). 
The purposes for adding these compounds to 
foods cover a broad spectrum-from anticaking 
agents (silicates in table salt) to those com-
pounds which can migrate into foods from 
packaging materials (waxes and starch). The 
GRAS compounds vary widely in their chemi-
cal composition and nature. Some are highly 
purified, synthetic chemicals of well-defined 
structure; others are relatively crude, natural 
products, such as the plant gums. The detailed 
specifications for "food grade" GRAS sub-
stances with maximum levels of toxic metals 
and other specified contaminants permitted are 
generally to be found in the Food Chemicals 
Codex. 3 For an appreciable number of GRAS 
substances, however, no specifications are giv-
en. Even when described in the Food Chemi-
cals Codex, the tolerances permitted for many 
GRAS substances are sufficient to allow poten-
tially toxic or undesirable impurities to be 
present. The specifications for the plant gums 
are particularly deficient in this respect. Some 
of the natural products used as seasoning or 
flavoring agents (garlic, dill, mustard, rue) are, 
by their nature, of variable composition and 
may contain ingredients that may be of concern, 
as safrole in nutmeg oil. Fortunately, most of 
the GRAS compounds added to foods or migrat-
ing into foods from packing materials are con-
sumed in extremely small quantities, a few mil-
ligrams or less per day. Unless the diet is most 
unusual, or the components are highly toxic or 
potent, we are thus protected from a number of 
potential interactions with therapeutic agents 
which might otherwise occur. Hydrogenated 
fish oil is GRAS, and fish oils may be contami-
nated with insecticides and other residues that 
would be of concern if large amounts were 
eaten. The GRAS status of hydrogenated fish 
oil, however, applies only in regard to the 
amount migrating to food from cotton packag-
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ing material, not as a direct food ingredient. 
The limitation on use imposed by each of the 
GRAS categories (Table I) must be taken into 
account, not just the fact that the substance is 
GRAS, in considering possible interactions 
with therapeutic agents. Of course, some sub-
stances are GRAS for more than one purpose. 
Ascorbic acid is permitted as both a chemical 
preservative and as a nutrient. In calculating the 
total daily intake of the substances the multiple 
uses, if permitted, must be added. 
An important point about the definition of 
GRAS substances should be mentioned. They 
are added to foods, of course, but from a legal 
standpoint, they are not "food additives." 
Food additives are substances added to foods 
within some specific tolerance level. GRAS 
substances can be added for the purpose in-
tended with no specified limits other than those 
determined by standard manufacturing practice. 
There are a few exceptions, in which GRAS 
substances have food additive-like limitations. 
Caffeine is GRAS and is added to baked goods 
and to cola beverages; the concentration of caf-
feine in cola drinks cannot exceed 0.02% in the 
final product, taking into account the natural 
caffeine content of the cola extract. Phar-
macologists and toxicologists familiar with the 
activity of caffeine as a stimulant and its other 
pharmacologic activities might anticipate that 
caffeine as a GRAS substances should lead to a 
number of interactions with other drugs. Limi-
tation on the level of caffeine permitted in cola 
drinks reduces the probability for such interac-
tions, unless large volumes are consumed. 
The Select Committee has found the evalua-
tion of the safety of GRAS substances to be a 
rather difficult assignment. Perhaps the most 
troublesome aspect of the review process has 
been the lack of adequate biologic and toxi-
cologic information from the world literature 
on so many of these compounds. For many sub-
stances there is no adequate acute or chronic 
animal oral toxicity information, and relatively 
few GRAS substances have been studied in man 
to determine their metabolic fate and disposi-
tion. Oral administration is obviously the rele-
vant route for evaluating the safety of the 
GRAS compounds. The Committee has often 
been in the position of having some parenteral 
toxicity data, but no information on the absorb-
ability of the compound when given orally. 
The Select Committee has noted in its reports 
what additional information is most needed for 
each substance reviewed and has given an indi-
cation of priority ranking since to obtain all 
these scientific data would be an enormous un-
dertaking and require many years of research. 
A particularly difficult problem for the 
Committee has been the estimation of consumer 
exposure: what foods are consumed and how 
much of each are eaten by people of different 
ages and dietary habits? Data were supplied to 
the Select Committee by a National Research 
Council Subcommittee4 on the consumption of 
GRAS substances. Their survey is the most 
comprehensive of any available at present, but 
the estimates of average daily consumption of 
the various GRAS substances are regularly in 
excess of actual consumption. In some in-
stances the NRC subcommittee estimates ex-
ceeded by 100 to 1,000 times the total amount 
of the substance known to be added to foods. 
The latter amounts could be calculated from 
poundage figures provided by producers of the 
compounds for food manufacturers. Safety 
evaluation requires a reasonable estimation of 
the amount consumed on the average, and the 
amounts special groups (babies, infants on spe-
cial formulas, teenagers, etc.) might consume if 
their diet selection included foods containing 
the highest amounts of the GRAS substances. 
Another factor to consider is the current trend in 
the use of GRAS substances and the changing 
patterns in consumer eating habits. The Select 
Committee is expected to evaluate the health 
aspects of the GRAS substances as currently 
used, and as might reasonably be expected to be 
used in the future. For example, the NRC sub-
committee figures indicate that the average per-
son (over 2 years old) consumes over 30 gm of 
sorbitol per day. Other estimates based on the 
quantity used in foods, or on production and 
import figures, are about one hundred times 
smaller. The higher figure is close to the level 
known to have a laxative effect in adults, and 
there would be reason for concern that people 
might be eating more sorbitol than they should; 
the lower, more realistic figure leads to the con-
clusion that the current intake, as an average 
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figure, is not excessive. The uncertainties about 
the NRC subcommittee's figures have been rec-
ognized, and that group is now in the process of 
conducting a new survey and revising its 
methods for calculating consumption data. 
GRAS substances-drug interactions 
It may be disappointing to some, but I have 
found no serious instance of GRAS substance-
drug interactions in all of the literature on 
GRAS compounds we have received which are 
not well known and generally recognized. 
Many inorganic salts and metal salts are GRAS, 
and there are numerous examples of one salt 
influencing the solubility and absorption of an-
other, but this type of interaction needs no de-
tailed discussion. Alginates, vegetable oils, 
phosphate salts, and other inorganic GRAS 
salts can influence the absorption of many trace 
metals as well as iron and calcium. 
More specific interactions can be cited. 
Sulfite is known to cause the destruction of 
thiamine, but this has been recognized for many 
years. In fact, there is a specific federal regula-
tion which prohibits the use of sulfites as chem-
ical preservatives in foods that represent major 
sources of dietary thiamine. The use of sulfites 
in foods presents a special problem in calculat-
ing the amount present in foods as eaten. Most 
of the sulfite is used during food processing 
steps, and much of it is lost before consump-
tion. 
Another possible interaction with drugs can 
be proposed on the basis of animal studies with 
the GRAS compounds: BHA (butylated hy-
droxyanisole) and BHT (butylated hy-
droxytoluene). Both compounds are added to 
foods as chemical preservatives but both are 
regulated GRAS and can be added up to 0.02% 
of the fat content of the food, such as potato 
chips. These antioxidants are effective inducers 
of liver microsomal enzymes and cause hepatic 
hypertrophy. If enough were eaten, the com-
pounds might induce more rapid metabolism of 
many drugs in the liver. The question remains 
unanswered as to whether the intake of these 
substances (within the tolerance limit specified) 
in man is sufficient to produce a significant in-
ductive effect on drug metabolism, and perhaps 
on steroid hormone metabolism in the liver. 
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BHT is more potent than BHA as an inducer in 
the animals studied, but more human studies are 
needed. 
There is a special type of allergic hypersen-
sitivity associated with some of the plant gums 
which should be mentioned. Gum acacia, 
tragacanth, and karaya are the ones most fre-
quently involved, and there appears to be some 
cross-sensitivity among these gums. The plant 
gums are used as stabilizers and thickening 
agents in a variety of foods so that it is difficult 
to avoid them if an allergic reaction develops. 
Some of these gums, particularly gum acacia, 
are also used in a number of pharmaceutical 
preparations. A hypersensitive person might 
appear to be allergic to a drug, but really be 
reacting to the plant gum in the pharmaceutical 
preparati on. 
One can imagine the possibility of competi-
tive interactions between drugs and GRAS sub-
stances in metabolic reactions, such an conjuga-
tion with glycine. Both aspirin and benzoic acid 
are converted to glycine conjugates in the liver. 
It is extremely unlikely, however, that enough 
benzoic acid would ever be present in the food 
to interfere with salicylic acid conjugation. 
In general, the low consumption of most 
GRAS substances precludes the interactions 
that would be expected if large amounts of these 
same compounds were ingested. Of course, re-
cent advances in our understanding of the com-
plex systems involved in drug metabolism open 
additional opportunities for interactions and 
modulation of drug metabolism by GRAS com-
pounds. The lack of new and unexpected exam-
ples of interactions in the GRAS compound lit-
erature may be more because of a lack of 
knowledge than an analysis based on adequate 
scientific evidence. There is certainly a need for 
continued alertness to such possibilities by clin-
ical pharmacologists. 
References 
I. General Services Administration, Office of the 
Federal Register, Code of Federal Regulations, 
Section 121.10 I, in Code of Federal Regulations. 
Title 21, Food and Drugs. Parts 10 to 199 rev., 
Washington, D. C., 1976, U. S. Government 
Printing Office. 
2. General Services Administration, Office of the 
Federal Register, Code of Federal Regulations, 
Volume 22 
Number 5 Part 2 
GRAS substances on pharmacologic effects of drugs 747 
Section 121.1163 and 121.1164, in Code of Fed-
eral Regulations. Title 21. Food and Drugs. Parts 
10 to 199 rev., Washington, D. c., 1976, U. S. 
Government Printing Office. 
3. National Research Council, Committee on Food 
Protection: Food Chemicals Codex, ed 2, Wash-
ington, D. C., 1972, National Academy of Sci-
ences. 
4. National Research Council, Committee on Food 
Protection, Subcommittee on Review of GRAS 
List (Phase II): A comprehensive survey of indus-
tryon the use of food chemicals generally recog-
nized as safe (GRAS), Washington, D. c., 1972, 
National Academy of Sciences. 
Discussion 
Dr. Vesell: Hershey, Pa.: I have heard esti-
mates by people testifying before Congress that 
although it may be minute amounts in anyone 
product, that humans consume approximately 
three pounds a year of all the GRAS and related 
substances. 
But more important, really, is an anecdotal 
study that I heard about in which a physician, or 
actually several physicians, have started putting 
hyperkinetic children on diets that are as free of 
these additives as possible and state rather 
dogmatically that these children improved 
rather markedly. 
Dr. La Du: I have a reprint with me called 
Report to the Nutrition Foundation by the Na-
tional Advisory Committee on Hyperkinesis 
and Food Additives. 
A national study has been undertaken to an-
swer this question about hyperkinetic children 
and food additives. Dr. B. Feingold in Califor-
nia has claimed that the hyperactivity in chil-
dren is due to these food additives. 
However, his main target is the food coloring 
materials, Red No.2, among others. 
Our Select Committee is not reviewing these 
additives. I don't know much about them, but 
there have been enough people with similar 
claims and a national committee was selected, 
which looked over the information and decided 
that the only solution was to have the proper 
kind of scientific study, and this is now under 
way. 
It's hard for me to imagine that small 
amounts of these substances can interfere with 
metabolism and affect behavior so dramati-
cally. There are enough reports from doctors 
who have treated children and say that they 
have been cleared of their hyperkinesis by the 
exclusion of these food additives so it is worth 
studying carefully. 
Dr. Melmon, San Francisco, Calif.: Your 
Select Committee is expected to study the 
safety or toxicity of substances which have been 
classified as being generally recognized as safe. 
Has that committee reviewed the reasons or 
the rationale for including or excluding sub-
stances from the GRAS list? How does the 
GRAS list differ from food additives and dyes? 
Are the others being evaluated? 
Dr. La Du: We were asked by the FDA to 
review just the GRAS substances. Another 
committee like ours is going to review the flav-
oring agents and another committee like ours 
presumably will review the food coloring 
agents. 
Questions came up very early in our Commit-
tee about what we were to do about GRAS sub-
stances where there was very little information. 
In other words, is the safest compound the one 
you know the least about? As a scientific com-
mittee, we would like some minimal standards 
for GRAS approval, but we realized that if we 
insisted on standards that would make sense in 
terms of drug safety, nothing would be ap-
proved as GRAS. There are compounds that we 
have refused to review, saying that there just 
wasn't enough information. We also have made 
recommendations about what ought to be done 
further with many GRAS substances and this is 
included in our reports. We've tried to be selec-
tive about recommendations and have given 
reasonable priorities about what is needed most 
to do. 
This is the first time that these compounds 
have ever been reviewed in this way. Even the 
World Health Organization didn't have the 
world literature collected, assimilated, and or-
ganized for them. 
Dr. Murphy, Boston, Mass.: You men-
tioned the gums and the evidence suggesting 
there were allergic reactions in some people as-
sociated with these. What does your Committee 
feel is the solution to this kind of a hypersensi-
tivity? 
Dr. La Do: We feel that one step is to define 
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better standards of purity and composition. 
Present standards allow proteinaceous material 
in the gums which may be important in deter-
mining allergic reactions. There is the general 
problem with many of these natural GRAS sub-
stances. Better standards for food grade mate-
rials would help establish whether the allergic 
reactions are due to impurities or to gum mate-
rial, itself. 
The other thing that would help is to identify 
which gum is present on the label of the prod-
uct. Simply indicating vegetable gum or plant 
gum doesn't help the allergic consumer. Label-
ing contents, however, is a complicated prob-
lem for food products and the FDA. 
Dr. Murphy: What you are saying about 
gums could apply to vegetable oils because the 
same situation holds. The label may say pure 
vegetable oil, but the mixture changes from 
season to season, year to year, depending on 
whether the crop of peanuts was good that year 
or not. These, oftentimes, are contaminated 
with protein from the vegetables, and people 
know that they are allergic to certain proteins 
but can't tell whether they are present in the oils 
or not. 
Dr. La Du: We have suggested this problem 
might be solved by labeling, but the FDA may 
find a better solution. 
Dr. Murphy: Have you noticed, in your 
committee, as I experienced on a similar com-
mittee related to the flavors, that an allergic 
response to a food additive is of little concern 
because, theoretically, it occurs at low fre-
quency; yet, when you ask what frequency, it 
may be as much as one percent. As you know, 
this is a pretty high frequency. 
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Dr. La Du: I think our Committee is dealing 
regularly with problems like this. Averaging in-
take for the total population is not very helpful, 
because we know the "average" doesn't apply 
to select groups within the population. 
High iron intake, for example, may be a 
hazard to a subpopulation that has a disturbance 
in the regulation of iron absorption, leading to 
iron accumulation in the liver if they take extra 
iron in their food. Probably most people can 
tolerate this load of iron, but is it good for the 
public to have the daily iron requirement 
present in about six different food products? 
Dr. Murphy: Isn't there also the problem of 
knowing exactly what you are getting? 
If the standards for food grade GRAS sub-
stances are so broad, they can include other 
things. Even if you were able to single out rep-
resentative populations to test unusual reac-
tions, you'd still not be giving something that 
would be a uniform and representative GRAS 
substance. 
Dr. La Du: Yes, the food grade speci-
fications could certainly be improved. For 
example, talc-coated rice is still available, but 
there is no definition of food grade talc. Talc 
can contain asbestos fibers; but you get into the 
difficult question, then, of whether oral asbes-
tos fibers are a hazard or not. Most of the food 
grade specifications were developed years ago 
based on analytic methods of that period. 
Newer methods of analysis would be worth-
while in assuring quality of the substances 
added to foods and help clear up some of the 
uncertainty about the importance of contami-
nants in explaining unusual or allergic reactions 
to some of the GRAS substances. 
